- ALSO READ
The Drugs Technical Advisory Board (DTAB) is likely to meet on Monday to decide the fate of 19 fixed-dose combinations (FDCs) drugs that are considered 'irrational combinations'.
Some of the common medicine brands which are under the scanner include cough syrup Ascoril C, TeddyKoff, and some cold medicines like D'Cold Total, Dolo Cold, headache medicines like Saridon etc.
The drugmakers have been asked to generate additional data on these drugs through phase-4 trials (trials done after marketing approval).
The expert panel is also likely to discuss the fate of codeine-based medicines. Sources say that the Central Drugs Standard Control Organisation (CDSCO) is focussing on phasing out irrational FDCs and codeine-based formulations in a phased manner.
In 2018, the government banned 343 FDC drugs on the advice of DTAB.
At that time, the FDC drugs comprised almost 50 per cent of the Rs 1.25-trillion domestic market in 2018.
Respiratory molecules form the bulk of the FDCs under the scanner.
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Mon, September 26 2022. 10:10 IST